The Duke Orthopaedic Journal

Register      Login

VOLUME 8 , ISSUE 1 ( June, 2018 ) > List of Articles


Arthritis Mutilans of the Shoulder: A Rare Cause for Rapidly Destructive Arthritis of the Shoulder

Lior Laver, Mark R Paiste, Mark D Lazarus, Grant E Garrigues

Keywords : Charcot-like arthropathy, Psoriatic arthritis mutilans, Rapidly destructive arthritis, Shoulder hemiarthroplasty.

Citation Information : Laver L, Paiste MR, Lazarus MD, Garrigues GE. Arthritis Mutilans of the Shoulder: A Rare Cause for Rapidly Destructive Arthritis of the Shoulder. The Duke Orthop J 2018; 8 (1):16-21.

DOI: 10.5005/jp-journals-10017-1089

License: CC BY-NC 3.0

Published Online: 01-05-2017

Copyright Statement:  Copyright © 2018; The Author(s).


Psoriatic arthritis (PsA) mutilans is a rare form of PsA that is extremely destructive, mimicking a charcot-like arthropathy. To date, the mutilans form of PsA has been described in the knee, spine, and elbow, but, to the best of our knowledge, this is the first report of this condition in the shoulder. This is a case presentation of a 59-year-old male with PsA demonstrating near complete and rapid disappearance of his right proximal humerus over the span of a few weeks. After a thorough diagnostic work-up, the patient was treated definitively with a hemiarthroplasty with improvement in his pain and range of motion (ROM) and satisfactory functional outcomes. Currently, there have not been any published recommendations for the diagnosis and management of arthritis mutilans of the shoulder, and we review our diagnostic and treatment strategy.

PDF Share
  1. Cantini F, Piccoli L, Nannini C, Kaloudi O, Bretoni M, Cassarà E. Psoriatic arthritis: a systematic review. Int J Rheum Dis 2010 Oct;13(4):300-317.
  2. Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973;3(1):55-78.
  3. Candia L, Cuellar ML, Marlowe SM, Marquez J, Iglesias A, Espinoza LR. Charcot-like arthropathy: a newly-recognized subset of psoriatic arthritis. Clin Exper Rheumatol 2006 Mar- Apr;24(2):172-175.
  4. Pomerantz RG, Mody E, Husni ME, Qureshi AA. Follow-up of psoriatic arthritis mutilans patients treated with anti-TNFalpha therapy. J Drugs Dermatol 2009 Apr;8(4):406-412.
  5. Bell L, Murphy CL, Wynne B, Cunanne G. Acute presentation of arthritis mutilans. J Rheumatol 2011 Jan;38(1):174-175.
  6. Bruzzese V, Marrese C, Ridola L, Zullo A. Psoriatic arthritis mutilans: case series and literature review. J Rheumatol 2013 Jul;40(7):1233-1236.
  7. Rodriguez-Moreno J, Bonet M, Del Blanco-Barnusell J, Castaño C, Clavaguera T, Mateo-Soria L, Roig-Vilaseca D, Ruiz-Martin JM. Mutilating/resorptive arthritis. A study of 24 patients in a series of 360 patients with psoriatic arthritis. Reumatol Clin 2013 Jan-Feb;9(1):38-41.
  8. Iofin I, Levine B, Badlani N, Klein GR, Jaffe WL. Psoriatic arthritis and arthroplasty: a review of the literature. Bull NYU Hosp Joint Dis 2008;66(1):41-48.
  9. Chandran V, Thavaneswaran A, Pellett FJ, Gladman DD. The association between Human Leukocyte Antigen and Killercell Immunoglobulin-like receptor gene variants and the development of arthritis mutilans in patients with psoriatic arthritis. Arthritis Rheum 2011;63:S532.
  10. Chandran V, Cook RJ, Thavaneswaran A, Gladman DD. Parametric survival analysis as well as multi-state analysis confirms the association between Human Leukocyte Antigen alleles and the development of Arthritis Mutilans in patients with psoriatic arthritis. J Rheumatol 2012;39(8):1723.
  11. Rahman P, Gladman DD, Cook RJ, Zhou Y, Young G, Salonen D. Radiological assessment in psoriatic arthritis. Br J Rheumatol 1998 Jul;37(7):760-765.
  12. Moll JM. The clinical spectrum of psoriatic arthritis. Clin Orthop Relat Res 1979 Sep;(143):66-75.
  13. Marsal S, Armadans-Gil L, Martínez M, Gallardo D, Ribera A, Lience E. Clinical, radiographic and HLA associations as markers for different patterns of psoriatic arthritis. Rheumatology (Oxford) 1999 Apr;38(4):332-337.
  14. McGonagle D, Conaghan PG, Emery P. Psoriatic arthritis: a unified concept twenty years on. Arthritis Rheum 1999 Jun;42:1080-1086. Erratum in Arthritis Rheum 1999 Sep;42(9):1997.
  15. Iannello S, Camuto M, Cavaleri A, Fagone S, Belfiore F. Psoriasis complicated with severe mutilating psoriatic osteoarthropathy. Clinical case and review of the literature. Minerva Med 2000 Sep;91(9):191-226.
  16. Kudo H. Non-constrained elbow arthroplasty for mutilans deformity in rheumatoid arthritis. A report of six cases. J Bone Joint Surg Br 1998 Mar;80(2):234-239.
  17. Pasquali P, Vertova F. On a case of epiphysiolytic osteoarthropathy (arthritis mutilans) with spinal localization. Chir Organi Mov 1961 Jun;50:329-337.
  18. Takagi H, Hirose K, Iwata H. Difficult cases of total knee arthroplasty. Clin Calcium 2004 Jul;14(7):118-121.
  19. Tan YM, Østergaard M, Doyle A, Dalbeth N, Lobo M, Reeves Q, Robinson E, Taylor WJ, Jones PB, Pui K, et al. MRI bone oedema scores are higher in the arthritis mutilans form of psoriatic arthritis and correlate with high radiographic scores for joint damage. Arthritis Res Ther 2009;11(1):R2.
  20. Bulbul R, Williams WV, Schumacher HR Jr. Psoriatic arthritis. Diverse and sometimes highly destructive. Postgrad Med 1995 Apr;97(4):97-99, 103-106, 108.
  21. Garcia-Valladares I, Cuchacovich R, Espinoza LR. Psoriatic arthritis: Radiographic joint repair following etanercept therapy. J Rheumatol 2012 Jan;39(1):185.
  22. McQueen F, Lloyd R, Doyle A, Robinson E, Lobo M, Exeter M, Taylor WJ, Jones P, Reid IR, Dalbeth N. Zoledronic acid does not reduce MRI erosive progression in PsA but may suppress bone oedema: the Zoledronic Acid in Psoriatic Arthritis (ZAPA) Study. Ann Rheum Dis 2011 Jun;70:1091-1094.
  23. Anandarajah AP, Schwarz EM, Totterman S, Monu J, Feng CY, Shao T, Haas-Smith SA, Ritchlin CT. The effect of etanercept on osteoclast precursor frequency and enhancing bone marrow oedema in patients with psoriatic arthritis. Ann Rheum Dis 2008 Mar;67(3):296-301.
  24. Marzo-Ortega H, McGonagle D, Rhodes LA, Tan AL, Conaghan PG, O'Connor P, Tanner SF, Fraser A, Veale D, Emery P. Efficacy of infliximab on MRI-determined bone oedema in psoriatic arthritis. Ann Rheum Dis 2007 Jun;66(6): 778-781.
  25. Van der Heijde D, Kavanaugh A, Gladman DD, Antoni C, Krueger GG, Guzzo C, Zhou B, Dooley LT, de Vlam K, Geusens P, et al. Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment. Arthritis Rheum 2007 Aug; 56(8):2698-2707.
  26. Ciocca MF. Bilateral shoulder pain: psoriatic arthritis masquerading as overuse. Phys Sportsmed 1998 Sep;26(9):50-55.
  27. Eder L, Chandran V, Gladman DD. Repair of radiographic joint damage following treatment with etanercept in psoriatic arthritis is demonstrable by 3 radiographic methods. J Rheumatol 2011 Jun;38(6):1065-1070.
  28. Williams GR, Rockwood CA. Hemiarthroplasty in rotator cuff-deficient shoulders. J Shoulder Elbow Surg 1996 Sep- Oct;5(5):362-367.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.